PharmaCyte Biotech (EFYA) Stock Statistics & Valuation Metrics
Total Valuation
PharmaCyte Biotech has a market cap or net worth of EUR 3.47M. The enterprise value is -EUR 14.82T.
- Market Cap
- EUR 3.47M
- Enterprise Value
- -EUR 14.82T
Share Statistics
PharmaCyte Biotech has 10,735,649 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 10,735,649
- Owned by Insiders
- 6.93%
- Owned by Institutions
- 2.25%
Financial Efficiency
PharmaCyte Biotech’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -14.92%.
- Return on Equity (ROE)
- -0.58
- Return on Assets (ROA)
- -0.42
- Return on Invested Capital (ROIC)
- -14.92%
- Return on Capital Employed (ROCE)
- -0.15
- Revenue Per Employee
- 0
- Profits Per Employee
- -9.71M
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of PharmaCyte Biotech is -0.15. PharmaCyte Biotech’s PEG ratio is -0.00.
- PE Ratio
- -0.15
- PS Ratio
- 0.00
- PB Ratio
- 0.13
- Price to FCF
- -0.98
- Price to Operating Cash Flow
- -0.98
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, PharmaCyte Biotech had revenue of 0 and earned -19.42M in profits. Earnings per share was -2.77.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -6.85M
- Pretax Income
- -19.42M
- Net Income
- -19.42M
- EBITDA
- -5.30M
- Earnings Per Share (EPS)
- -2.77
Cash Flow
In the last 12 months, operating cash flow was -3.94M and capital expenditures 0, giving a free cash flow of -3.94M billion.
- Operating Cash Flow
- -3.94M
- Free Cash Flow
- -3.94M
- Free Cash Flow per Share
- -0.37
Dividends & Yields
PharmaCyte Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -90.17%
- Earnings Yield
- -369.52%
Stock Price Statistics
- Beta
- ―
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 2.52
- 200-Day Moving Average
- 2.52
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- 500
Important Dates
PharmaCyte Biotech upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- Mar 16, 2022
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
PharmaCyte Biotech as a current ratio of 45.28, with Debt / Equity ratio of 0.00%
- Current Ratio
- 45.28
- Quick Ratio
- 45.28
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 3.51
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, PharmaCyte Biotech has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
PharmaCyte Biotech EV to EBITDA ratio is 2.45, with an EV/FCF ratio of 3.39.
- EV to Sales
- 0.00
- EV to EBITDA
- 2.45
- EV to Free Cash Flow
- 3.39
- EV to Operating Cash Flow
- 3.39
Balance Sheet
PharmaCyte Biotech has EUR 30.51M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 30.51M billion.
- Cash & Marketable Securities
- EUR 30.51M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 30.51M
- Net Cash Per Share
- EUR 2.84
- Tangible Book Value Per Share
- EUR 2.78
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
